Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
LetterLetters to the Editor

Semiquantification Limitations: FMTVDM©℗ Demonstrates Quantified Tumor Response to Treatment with Both Regional Blood Flow and Metabolic Changes

Richard M. Fleming, Matthew R. Fleming, Andrew McKusick and Tapan K. Chaudhuri
Journal of Nuclear Medicine October 2018, 59 (10) 1643-1644; DOI: https://doi.org/10.2967/jnumed.118.217018
Richard M. Fleming
*FHHI-OmnificImaging-Camelot 707 E. Grand Ave., #8 El Segundo, CA 90245 E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: DrRichardMFleming@gmail.com
Matthew R. Fleming
*FHHI-OmnificImaging-Camelot 707 E. Grand Ave., #8 El Segundo, CA 90245 E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: DrRichardMFleming@gmail.com
Andrew McKusick
*FHHI-OmnificImaging-Camelot 707 E. Grand Ave., #8 El Segundo, CA 90245 E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: DrRichardMFleming@gmail.com
Tapan K. Chaudhuri
*FHHI-OmnificImaging-Camelot 707 E. Grand Ave., #8 El Segundo, CA 90245 E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: DrRichardMFleming@gmail.com
  • Article
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR: True quantification (1–6) is the actual measurement of material within a tested region. In molecular imaging, the ability to accurately measure isotope accumulation is dependent on the demonstration that the measuring device, be it a SPECT or PET camera, is accurately calibrated, is measuring the correct isotope, and can be counted and reproduced serially.

The publication by Humbert et al. (7) is important because it raises the question of whether PET cameras can detect actual changes in disease after treatment. To accurately measure changes in regional blood flow and metabolism it is necessary to rely on a truly quantified (1–6) method and not on a method that produces only a calculated value. The Humbert et al. (7) method makes 2 flawed presumptions. First, it applies the wrong pharmacologic kinetic model that the isotope absent from the arterial bed traveled only to the site of interest. Second, it uses a matrix setting, which has been demonstrated to produce a loss of signal data, which produces a significant error rate (2–6). This method produces a semiquantified value derived from “first-pass extraction,” not an accurate measurement of the amount of isotope within the tissue of interest.

We have demonstrated that using a true quantification method provides an actual measurement of change in regional blood flow and metabolism, which is useful in assessment of treatment response.

Footnotes

  • Published online Jul. 20, 2018.

  • © 2018 by the Society of Nuclear Medicine and Molecular Imaging.

REFERENCES

  1. 1.↵
    1. Fleming RM,
    2. Dooley WC,
    3. Chaudhuri TK
    . The development of FMTVDM-BEST IMAGING©℗: the answer for breast cancer. Breast enhanced scintigraphy test (BEST©℗): quantifying the detection of breast cancer and its treatment. J Nucl Med Radiat Ther. 2017;8:350.
    OpenUrl
  2. 2.↵
    1. Fleming RM,
    2. Fleming MR,
    3. Chaudhuri T,
    4. McKusick A,
    5. Dooley WC,
    6. Glover C
    . Both percent diameter stenosis (%DS) and coronary flow reserve can be derived directly from myocardial perfusion imaging using FMTVDM and measurement of isotope redistribution. J Nucl Med Radiat Ther 2018;9:1000353.
    OpenUrl
  3. 3.
    1. Fleming RM,
    2. Fleming MR,
    3. McKusick A,
    4. Chaudhuri T
    . The Fleming method for tissue and vascular differentiation and metabolism (FMTVDM) using same state single or sequential quantification comparisons©℗: an evolutionary quantum leap forward for nuclear cardiology & nuclear medicine. JVasc Dz & Treat. 2018;2:1–6.
    OpenUrl
  4. 4.
    1. Fleming RM,
    2. Fleming MR,
    3. Dooley WC,
    4. McKusick A
    . FMTVDM-BEST©℗ breast cancer imaging eliminates the fear of having BRCA1 and BRCA2 breast cancer genes. J Clin Mol Med. 2018;1:1–2.
    OpenUrl
  5. 5.
    1. Fleming RM,
    2. Fleming MR,
    3. Dooley WC,
    4. Sheikh A,
    5. McKusick A,
    6. Chaudhuri T
    . FMTVDM–FHRWW & B.E.S.T. the first true “quantitative” nuclear imaging protocols with proprietary equations following the Fleming method (TFM) for nuclear scintillation equipment quantitative standardization. Biomed J Sci & Tech Res 2018;4:1-4.
    OpenUrl
  6. 6.↵
    1. Fleming RM,
    2. Fleming MR,
    3. McKusick A,
    4. Chaudhuri T
    . FMTVDM-TFM©℗: true quantification requires standardization of the tool being used to measure, with a known, unchanging standard to produce accurate, consistent and reproducible quantified measurements. J Nucl Cardiol. June 19, 2018 [Epub ahead of print].
  7. 7.↵
    1. Humbert O,
    2. Lasserre M,
    3. Bertaut A,
    4. et al
    . Breast cancer blood flow and metabolism on dual-acquisition 18F-FDG PET: correlation with tumor phenotype and neoadjuvant chemotherapy response. J Nucl Med. 2018;59:1035–1041.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (10)
Journal of Nuclear Medicine
Vol. 59, Issue 10
October 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Semiquantification Limitations: FMTVDM©℗ Demonstrates Quantified Tumor Response to Treatment with Both Regional Blood Flow and Metabolic Changes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Semiquantification Limitations: FMTVDM©℗ Demonstrates Quantified Tumor Response to Treatment with Both Regional Blood Flow and Metabolic Changes
Richard M. Fleming, Matthew R. Fleming, Andrew McKusick, Tapan K. Chaudhuri
Journal of Nuclear Medicine Oct 2018, 59 (10) 1643-1644; DOI: 10.2967/jnumed.118.217018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Semiquantification Limitations: FMTVDM©℗ Demonstrates Quantified Tumor Response to Treatment with Both Regional Blood Flow and Metabolic Changes
Richard M. Fleming, Matthew R. Fleming, Andrew McKusick, Tapan K. Chaudhuri
Journal of Nuclear Medicine Oct 2018, 59 (10) 1643-1644; DOI: 10.2967/jnumed.118.217018
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Unraveling the Hypocalcemic Response to 177Lu-Prostate-Specific Membrane Antigen Therapy
  • Addendum to MIRD Pamphlet No. 28
  • Potential of 188Re as an Alternative to 177Lu and Dosimetric Consequences
Show more Letters to the Editor

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire